In March 2019, the Food and Drug Administration approved esketamine (SPRAVATO™) nasal spray to be used in conjunction with an oral antidepressant, for the treatment of treatment-resistant depression (TRD) in adults.¹ TRD affects almost...
Read More
Over the years I have noticed that consumers have a very difficult time understanding the quality of a scientific report, whether it is a book, a magazine or journal article. Scientific knowledge is based...
The objective of ResearchInPlainEnglish is to provide an unbiased review of recent biomedical research publications in the areas of psychopharmacology, psychiatry, child psychiatry, intellectual disabilities, autism and genetic disorders. I will pick articles that...